Inflexion to carve out Rosemont Pharmaceuticals from US-listed Perrigo
UK private equity house Inflexion has agreed to carve-out liquid pharma business Rosemont Pharmaceuticals from US-listed Perrigo.
UK private equity house Inflexion has agreed to carve-out liquid pharma business Rosemont Pharmaceuticals from US-listed Perrigo.
Recent Comments